The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds IE-2023-01 and CD-2023-01 are now available on the EPEAT Registry. Both Rounds involved Level 2 investigations, which require laboratory testing of products to determine conformance with select EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org

The 2024 Schedule of EPEAT Continuous Monitoring Rounds is now available on the EPEAT Registry.

The EPEAT Program ensures the veracity of EPEAT-registered products through an ongoing surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes (called Continuous Monitoring Rounds). Participating Manufacturers are responsible for participating in these Rounds, cooperating with their CABs, and providing the necessary documentation to show conformance with EPEAT Criteria.

GEC is committed to transparency, and to this end, the 2024 EPEAT Continuous Monitoring Schedule and the subsequent results of each Round are made publicly available.

Please direct any questions about the 2024 Continuous Monitoring Schedule to EPEAT@gec.org.

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds IE-2023-02 and MP-2023-01 are now available on the EPEAT Registry. IE-2023-02 involved Level 0 investigations in the imaging equipment product category, which require CABs to review publicly available information to determine conformance with EPEAT Criteria. MP-2023-01 focused on products in the mobile phones product category and involved Level 2 investigations, which require laboratory testing of products to determine conformance with select EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org.

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Report for Continuous Monitoring Round MP-2023-02 is now available on the EPEAT Registry. This Round involved Level 0 investigations of products in the Mobile Phones category. Level 0 Investigations require CABs to review publicly available information to determine conformance with specific EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Report for Continuous Monitoring Round CD-2023-02 is now available on the EPEAT Registry. This Round involved Level 0 investigations of products in the Computers and Displays category. Level 0 Investigations require CABs to review publicly available information to determine conformance with specific EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds IE-2022-01 and IE-2022-03 are now available on the EPEAT Registry. IE-2022-01 involved laboratory evaluation of EPEAT-registered products in the Imaging Equipment product category against specific EPEAT Criteria, while IE-2022-03 involved documentation review.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds CD-2022-01, and IE-2022-04 are now available on the EPEAT Registry. CD-2022-01 involved laboratory evaluation of EPEAT-registered products in the Computers and Displays product category against specific EPEAT Criteria. IE-2022-04 involved the review of documentary evidence provided by Participating Manufacturers to demonstrate conformance with the EPEAT Criteria in the Imaging Equipment product category.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds TV-2022-01, and CD-2022-04 are now available on the EPEAT Registry. TV-2022-01 involved laboratory evaluation of EPEAT-registered products in the Televisions product category with specific EPEAT Criteria. CD-2022-04 involved review of documentary evidence provided by Participating Manufacturers to demonstrate conformance with the EPEAT Criteria selected for investigation in the Computers and Displays product category.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds CD-2022-03, MP-2022-03, MP-2022-04, SV-2022-04, TV-2022-03, and TV-2022-04 are now available on the EPEAT Registry.

All of the Rounds involved Level 1 Investigations. Level 1 Investigations require CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances, and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds MP-2022-02 and PV-2022-02 are now available on the EPEAT Registry.

Continuous Monitoring Round PV-2022-02 involved Level 1 Investigations in the Photovoltaic Modules and Inverters category, while MP-2022-02 involved Level 1 Investigations in the Mobile Phone category. Level 1 Investigations require CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Please contact us with any questions at EPEAT@gec.org

The 2023 Schedule of EPEAT Continuous Monitoring Rounds is now available on the EPEAT Registry.

The EPEAT Program ensures the veracity of EPEAT-registered products through an ongoing surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes (called Continuous Monitoring Rounds). Participating Manufacturers are responsible for participating in these Rounds, cooperating with their CABs, and providing the necessary documentation to show conformance with EPEAT Criteria.

GEC is committed to transparency, and to this end, the 2023 EPEAT Continuous Monitoring Schedule and the subsequent results of each Round are made publicly available.

Please direct any questions about the 2023 Schedule of EPEAT Continuous Monitoring Rounds to EPEAT@gec.org.

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received Major Nonconformances, and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds PV-2022-03 and SV-2022-01 are now available on the EPEAT Registry.

Continuous Monitoring Round PV-2022-03 involved Level 1 Investigations in the Photovoltaic Modules and Inverters category. Level 1 Investigations require CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Continuous Monitoring Round SV-2022-01 involved Level 2 Investigations of EPEAT-registered products in the Servers category. Level 2 Investigations require laboratory evaluation of products to determine their conformance with specific EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org.

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. Participating Manufacturers are responsible for participating in these Rounds, cooperating with their CABs, and providing the necessary documentation to demonstrate conformance with EPEAT Criteria.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received Major Nonconformances and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Report for Continuous Monitoring Round CD-2022-02 (which focused on Computers and Displays), is now available on the EPEAT Registry. This was a Level 1 Round, which requires CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Please contact us with any questions at EPEAT@gec.org

The EPEAT program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

On June 13, 2022, EPEAT launched a Level 1 Continuous Monitoring Round for the Computers and Displays product category. Level 1 Rounds involve investigations that use Documentation Review to determine the conformance of products with specific EPEAT Criteria.

In these investigations, Participating Manufacturers have a discrete period in which they must provide evidence that demonstrates conformance with the selected EPEAT Criteria. The plan for this Round (CD-2022-04) is now posted on the EPEAT Registry, and provides an overview of the investigative process, the total number of products selected, and the criteria selected for investigation. Key dates for this Round are as follows:

On the start date of the Round, GEC-approved CABs notify their Participating Manufacturer clients that their products have been selected for investigation and begin the evidence collection process.

Please contact us with any questions at EPEAT@gec.org.

The EPEAT program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

On June 20, 2022, EPEAT launched a Level 1 Continuous Monitoring Round for the Imaging Equipment product category. Level 1 Rounds involve investigations that use Documentation Review to determine the conformance of products with specific EPEAT Criteria.

In these investigations, Participating Manufacturers have a discrete period in which they must provide evidence that demonstrates conformance with the selected EPEAT Criteria. The plan for this Round (IE-2022-04) is now posted on the EPEAT Registry, and provides an overview of the investigative process, the total number of products selected, and the criteria selected for investigation. Key dates for this Round are as follows: 

On the start date of the Round, GEC-approved CABs notify their Participating Manufacturer clients that their products have been selected for investigation and begin the evidence collection process.

Please contact us with any questions at EPEAT@gec.org.

The EPEAT program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. Participating Manufacturers are responsible for participating in these Rounds, cooperating with their CABs, and providing the necessary documentation to demonstrate conformance with EPEAT Criteria.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received Major Nonconformances, and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds SV-2022-02 (which focused on Servers), and TV-2022-02 (which focused on Televisions), are now available on the EPEAT Registry. Both Rounds involved Level 1 Investigations, which require CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Please contact us with any questions at EPEAT@gec.org

The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. Participating Manufacturers are responsible for participating in these Rounds, cooperating with their CABs, and providing the necessary documentation to demonstrate conformance with EPEAT Criteria.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received major nonconformances and the actions taken to restore accuracy of the EPEAT Registry.

The Outcomes Report for Continuous Monitoring Round CD-2021-03 (which focused on the Computers and Displays product category), is now available on the EPEAT Registry. This Round involved Level 1 Investigations, which require CABs to review documentary evidence provided by Participating Manufacturers to demonstrate conformance.

Please contact us with any questions at EPEAT@gec.org

The EPEAT program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

On April 11, 2022, EPEAT launched a Level 1 Continuous Monitoring Round for the Computers and Displays product category. Level 1 Rounds involve investigations that use Documentation Review to determine the conformance of products with specific EPEAT Criteria.

In these Investigations, Participating Manufacturers have a discrete period in which they must provide evidence that demonstrates conformance with the selected EPEAT Criteria. The plan for this Computers and Displays Round (CD-2022-03) is now posted on the EPEAT Registry, and provides an overview of the investigative process, the total number of products selected, and the Criteria selected for investigation. Key dates for this Round are as follows:

On the start date of the Round, GEC-approved CABs notify their Participating Manufacturer clients that their products have been selected for investigation and begin the evidence collection process.

Please contact us with any questions at EPEAT@gec.org.

The EPEAT program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Continuous Monitoring activities include investigations planned by the EPEAT Program and implemented by GEC-approved Conformity Assurance Bodies (CABs) within discrete timeframes called Continuous Monitoring Rounds. For each Round, the EPEAT Program specifies the products and EPEAT Criteria to be investigated, the specific timeframe for investigative activities, and the method of investigation that CABs must use.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received major nonconformances and the actions taken to restore the accuracy of the EPEAT Registry. 

The Outcomes Report for Continuous Monitoring Round CD-2021-01 is now available on the EPEAT Registry. This Round involved Level 2 Investigations of EPEAT-registered products in the Computers and Displays product category. Level 2 Investigations require laboratory evaluation of products to determine their conformance with specific EPEAT Criteria.

Please contact us with any questions at EPEAT@gec.org.